Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Performance Evaluation of Dream OCT: AP Study

NCT: NCT07355491 · COMPLETED

NCT IDNCT07355491
StatusCOMPLETED
Start Date2025-12-16
Completion2026-05-12
SponsorIntalight, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.

Frequently Asked Questions

What is Performance Evaluation of Dream OCT: AP Study?

Performance Evaluation of Dream OCT: AP Study is a clinical trial registered under NCT07355491. Current status: COMPLETED.

What is the status of NCT07355491?

The current status of NCT07355491 (Performance Evaluation of Dream OCT: AP Study) is: COMPLETED.

When did Performance Evaluation of Dream OCT: AP Study start?

Performance Evaluation of Dream OCT: AP Study started on 2025-12-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.